home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 24, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 461 active entries

Amoytop Biotech Co., Ltd

5F, No. 61 Huming Road, Xiamen

Phone: 86-592-5140518
Fax: 86-592-5361826

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


AMOYTOP BIOTECH is the leading manufacturer of recombinant proteins in China, focusing on treatment of cancer and hematology. The products include: Molgramostim (gm-csf), Filgrastim (g-csf) and Oprelvekin (Interleukin, IL-11), provided as raw material and finished formulation in bulk; also Interferon alfa 2a, Interferon alfa 2b, Interferon gamma, Interleukin 2 (IL-2), Interleukin 4 (IL-4) and other bio-products as bio-reagent, with stable quality and high purity at competitive price. The annual production capacity are 500g of Molgramostim (gm-csf) and Filgrastim (g-csf) respectively and 3000g of Oprelvekin (IL-11) as raw material; 2 million vials of Molgramostim (gm-csf) and Filgrastim (g-csf) respectively and 1 million vials of Oprelvekin (IL-11) as finished product.

The SDA of China has granted AMOYTOP the Certificate of GMP. All the operations at the plant are performed under GMP Operation Guidelines and controlled under Quality Guarantee System.

AMOYTOP is the first and largest company to launch domestic Molgramostim in China in 1997. We are the Molgramostim Reference Standard supplier to the National Bioproduct Inspection Institute.

Selected Categories:

Product Company   Service Company
- General
- Research
- General
- Research
- General
- Research
- Medical

Last update of this entry: March 05, 2004

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.